Global Protein and Peptide Therapeutics Market Research Report 2024(Status and Outlook)
Report Overview
Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.
This report provides a deep insight into the global Protein and Peptide Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Protein and Peptide Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Protein and Peptide Therapeutics market in any manner.
Global Protein and Peptide Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
J & J
Market Segmentation (by Type)
Injection
Oral
Market Segmentation (by Application)
Cancer
Metabolic Disorders
Central Nervous System
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Protein and Peptide Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.
This report provides a deep insight into the global Protein and Peptide Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Protein and Peptide Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Protein and Peptide Therapeutics market in any manner.
Global Protein and Peptide Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
J & J
Market Segmentation (by Type)
Injection
Oral
Market Segmentation (by Application)
Cancer
Metabolic Disorders
Central Nervous System
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Protein and Peptide Therapeutics Market
- Overview of the regional outlook of the Protein and Peptide Therapeutics Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Protein and Peptide Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Protein and Peptide Therapeutics
1.2 Key Market Segments
1.2.1 Protein and Peptide Therapeutics Segment by Type
1.2.2 Protein and Peptide Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PROTEIN AND PEPTIDE THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Protein and Peptide Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Protein and Peptide Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PROTEIN AND PEPTIDE THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Protein and Peptide Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Protein and Peptide Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Protein and Peptide Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Protein and Peptide Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Protein and Peptide Therapeutics Sales Sites, Area Served, Product Type
3.6 Protein and Peptide Therapeutics Market Competitive Situation and Trends
3.6.1 Protein and Peptide Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Protein and Peptide Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PROTEIN AND PEPTIDE THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Protein and Peptide Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PROTEIN AND PEPTIDE THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PROTEIN AND PEPTIDE THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Protein and Peptide Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Protein and Peptide Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Protein and Peptide Therapeutics Price by Type (2019-2024)
7 PROTEIN AND PEPTIDE THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Protein and Peptide Therapeutics Market Sales by Application (2019-2024)
7.3 Global Protein and Peptide Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Protein and Peptide Therapeutics Sales Growth Rate by Application (2019-2024)
8 PROTEIN AND PEPTIDE THERAPEUTICS MARKET SEGMENTATION BY REGION
8.1 Global Protein and Peptide Therapeutics Sales by Region
8.1.1 Global Protein and Peptide Therapeutics Sales by Region
8.1.2 Global Protein and Peptide Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Protein and Peptide Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Protein and Peptide Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Protein and Peptide Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Protein and Peptide Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Protein and Peptide Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Sanofi
9.1.1 Sanofi Protein and Peptide Therapeutics Basic Information
9.1.2 Sanofi Protein and Peptide Therapeutics Product Overview
9.1.3 Sanofi Protein and Peptide Therapeutics Product Market Performance
9.1.4 Sanofi Business Overview
9.1.5 Sanofi Protein and Peptide Therapeutics SWOT Analysis
9.1.6 Sanofi Recent Developments
9.2 Teva
9.2.1 Teva Protein and Peptide Therapeutics Basic Information
9.2.2 Teva Protein and Peptide Therapeutics Product Overview
9.2.3 Teva Protein and Peptide Therapeutics Product Market Performance
9.2.4 Teva Business Overview
9.2.5 Teva Protein and Peptide Therapeutics SWOT Analysis
9.2.6 Teva Recent Developments
9.3 Novo Nordisk
9.3.1 Novo Nordisk Protein and Peptide Therapeutics Basic Information
9.3.2 Novo Nordisk Protein and Peptide Therapeutics Product Overview
9.3.3 Novo Nordisk Protein and Peptide Therapeutics Product Market Performance
9.3.4 Novo Nordisk Protein and Peptide Therapeutics SWOT Analysis
9.3.5 Novo Nordisk Business Overview
9.3.6 Novo Nordisk Recent Developments
9.4 Takeda
9.4.1 Takeda Protein and Peptide Therapeutics Basic Information
9.4.2 Takeda Protein and Peptide Therapeutics Product Overview
9.4.3 Takeda Protein and Peptide Therapeutics Product Market Performance
9.4.4 Takeda Business Overview
9.4.5 Takeda Recent Developments
9.5 Eli Lilly
9.5.1 Eli Lilly Protein and Peptide Therapeutics Basic Information
9.5.2 Eli Lilly Protein and Peptide Therapeutics Product Overview
9.5.3 Eli Lilly Protein and Peptide Therapeutics Product Market Performance
9.5.4 Eli Lilly Business Overview
9.5.5 Eli Lilly Recent Developments
9.6 AstraZeneca
9.6.1 AstraZeneca Protein and Peptide Therapeutics Basic Information
9.6.2 AstraZeneca Protein and Peptide Therapeutics Product Overview
9.6.3 AstraZeneca Protein and Peptide Therapeutics Product Market Performance
9.6.4 AstraZeneca Business Overview
9.6.5 AstraZeneca Recent Developments
9.7 Novartis
9.7.1 Novartis Protein and Peptide Therapeutics Basic Information
9.7.2 Novartis Protein and Peptide Therapeutics Product Overview
9.7.3 Novartis Protein and Peptide Therapeutics Product Market Performance
9.7.4 Novartis Business Overview
9.7.5 Novartis Recent Developments
9.8 AbbVie
9.8.1 AbbVie Protein and Peptide Therapeutics Basic Information
9.8.2 AbbVie Protein and Peptide Therapeutics Product Overview
9.8.3 AbbVie Protein and Peptide Therapeutics Product Market Performance
9.8.4 AbbVie Business Overview
9.8.5 AbbVie Recent Developments
9.9 Ipsen
9.9.1 Ipsen Protein and Peptide Therapeutics Basic Information
9.9.2 Ipsen Protein and Peptide Therapeutics Product Overview
9.9.3 Ipsen Protein and Peptide Therapeutics Product Market Performance
9.9.4 Ipsen Business Overview
9.9.5 Ipsen Recent Developments
9.10 Ferring
9.10.1 Ferring Protein and Peptide Therapeutics Basic Information
9.10.2 Ferring Protein and Peptide Therapeutics Product Overview
9.10.3 Ferring Protein and Peptide Therapeutics Product Market Performance
9.10.4 Ferring Business Overview
9.10.5 Ferring Recent Developments
9.11 Merck
9.11.1 Merck Protein and Peptide Therapeutics Basic Information
9.11.2 Merck Protein and Peptide Therapeutics Product Overview
9.11.3 Merck Protein and Peptide Therapeutics Product Market Performance
9.11.4 Merck Business Overview
9.11.5 Merck Recent Developments
9.12 The Medicines
9.12.1 The Medicines Protein and Peptide Therapeutics Basic Information
9.12.2 The Medicines Protein and Peptide Therapeutics Product Overview
9.12.3 The Medicines Protein and Peptide Therapeutics Product Market Performance
9.12.4 The Medicines Business Overview
9.12.5 The Medicines Recent Developments
9.13 J and J
9.13.1 J and J Protein and Peptide Therapeutics Basic Information
9.13.2 J and J Protein and Peptide Therapeutics Product Overview
9.13.3 J and J Protein and Peptide Therapeutics Product Market Performance
9.13.4 J and J Business Overview
9.13.5 J and J Recent Developments
10 PROTEIN AND PEPTIDE THERAPEUTICS MARKET FORECAST BY REGION
10.1 Global Protein and Peptide Therapeutics Market Size Forecast
10.2 Global Protein and Peptide Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Protein and Peptide Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Protein and Peptide Therapeutics Market Size Forecast by Region
10.2.4 South America Protein and Peptide Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Protein and Peptide Therapeutics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Protein and Peptide Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Protein and Peptide Therapeutics by Type (2025-2030)
11.1.2 Global Protein and Peptide Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Protein and Peptide Therapeutics by Type (2025-2030)
11.2 Global Protein and Peptide Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Protein and Peptide Therapeutics Sales (Kilotons) Forecast by Application
11.2.2 Global Protein and Peptide Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Protein and Peptide Therapeutics
1.2 Key Market Segments
1.2.1 Protein and Peptide Therapeutics Segment by Type
1.2.2 Protein and Peptide Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PROTEIN AND PEPTIDE THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Protein and Peptide Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Protein and Peptide Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PROTEIN AND PEPTIDE THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Protein and Peptide Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Protein and Peptide Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Protein and Peptide Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Protein and Peptide Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Protein and Peptide Therapeutics Sales Sites, Area Served, Product Type
3.6 Protein and Peptide Therapeutics Market Competitive Situation and Trends
3.6.1 Protein and Peptide Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Protein and Peptide Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PROTEIN AND PEPTIDE THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Protein and Peptide Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PROTEIN AND PEPTIDE THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PROTEIN AND PEPTIDE THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Protein and Peptide Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Protein and Peptide Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Protein and Peptide Therapeutics Price by Type (2019-2024)
7 PROTEIN AND PEPTIDE THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Protein and Peptide Therapeutics Market Sales by Application (2019-2024)
7.3 Global Protein and Peptide Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Protein and Peptide Therapeutics Sales Growth Rate by Application (2019-2024)
8 PROTEIN AND PEPTIDE THERAPEUTICS MARKET SEGMENTATION BY REGION
8.1 Global Protein and Peptide Therapeutics Sales by Region
8.1.1 Global Protein and Peptide Therapeutics Sales by Region
8.1.2 Global Protein and Peptide Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Protein and Peptide Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Protein and Peptide Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Protein and Peptide Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Protein and Peptide Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Protein and Peptide Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Sanofi
9.1.1 Sanofi Protein and Peptide Therapeutics Basic Information
9.1.2 Sanofi Protein and Peptide Therapeutics Product Overview
9.1.3 Sanofi Protein and Peptide Therapeutics Product Market Performance
9.1.4 Sanofi Business Overview
9.1.5 Sanofi Protein and Peptide Therapeutics SWOT Analysis
9.1.6 Sanofi Recent Developments
9.2 Teva
9.2.1 Teva Protein and Peptide Therapeutics Basic Information
9.2.2 Teva Protein and Peptide Therapeutics Product Overview
9.2.3 Teva Protein and Peptide Therapeutics Product Market Performance
9.2.4 Teva Business Overview
9.2.5 Teva Protein and Peptide Therapeutics SWOT Analysis
9.2.6 Teva Recent Developments
9.3 Novo Nordisk
9.3.1 Novo Nordisk Protein and Peptide Therapeutics Basic Information
9.3.2 Novo Nordisk Protein and Peptide Therapeutics Product Overview
9.3.3 Novo Nordisk Protein and Peptide Therapeutics Product Market Performance
9.3.4 Novo Nordisk Protein and Peptide Therapeutics SWOT Analysis
9.3.5 Novo Nordisk Business Overview
9.3.6 Novo Nordisk Recent Developments
9.4 Takeda
9.4.1 Takeda Protein and Peptide Therapeutics Basic Information
9.4.2 Takeda Protein and Peptide Therapeutics Product Overview
9.4.3 Takeda Protein and Peptide Therapeutics Product Market Performance
9.4.4 Takeda Business Overview
9.4.5 Takeda Recent Developments
9.5 Eli Lilly
9.5.1 Eli Lilly Protein and Peptide Therapeutics Basic Information
9.5.2 Eli Lilly Protein and Peptide Therapeutics Product Overview
9.5.3 Eli Lilly Protein and Peptide Therapeutics Product Market Performance
9.5.4 Eli Lilly Business Overview
9.5.5 Eli Lilly Recent Developments
9.6 AstraZeneca
9.6.1 AstraZeneca Protein and Peptide Therapeutics Basic Information
9.6.2 AstraZeneca Protein and Peptide Therapeutics Product Overview
9.6.3 AstraZeneca Protein and Peptide Therapeutics Product Market Performance
9.6.4 AstraZeneca Business Overview
9.6.5 AstraZeneca Recent Developments
9.7 Novartis
9.7.1 Novartis Protein and Peptide Therapeutics Basic Information
9.7.2 Novartis Protein and Peptide Therapeutics Product Overview
9.7.3 Novartis Protein and Peptide Therapeutics Product Market Performance
9.7.4 Novartis Business Overview
9.7.5 Novartis Recent Developments
9.8 AbbVie
9.8.1 AbbVie Protein and Peptide Therapeutics Basic Information
9.8.2 AbbVie Protein and Peptide Therapeutics Product Overview
9.8.3 AbbVie Protein and Peptide Therapeutics Product Market Performance
9.8.4 AbbVie Business Overview
9.8.5 AbbVie Recent Developments
9.9 Ipsen
9.9.1 Ipsen Protein and Peptide Therapeutics Basic Information
9.9.2 Ipsen Protein and Peptide Therapeutics Product Overview
9.9.3 Ipsen Protein and Peptide Therapeutics Product Market Performance
9.9.4 Ipsen Business Overview
9.9.5 Ipsen Recent Developments
9.10 Ferring
9.10.1 Ferring Protein and Peptide Therapeutics Basic Information
9.10.2 Ferring Protein and Peptide Therapeutics Product Overview
9.10.3 Ferring Protein and Peptide Therapeutics Product Market Performance
9.10.4 Ferring Business Overview
9.10.5 Ferring Recent Developments
9.11 Merck
9.11.1 Merck Protein and Peptide Therapeutics Basic Information
9.11.2 Merck Protein and Peptide Therapeutics Product Overview
9.11.3 Merck Protein and Peptide Therapeutics Product Market Performance
9.11.4 Merck Business Overview
9.11.5 Merck Recent Developments
9.12 The Medicines
9.12.1 The Medicines Protein and Peptide Therapeutics Basic Information
9.12.2 The Medicines Protein and Peptide Therapeutics Product Overview
9.12.3 The Medicines Protein and Peptide Therapeutics Product Market Performance
9.12.4 The Medicines Business Overview
9.12.5 The Medicines Recent Developments
9.13 J and J
9.13.1 J and J Protein and Peptide Therapeutics Basic Information
9.13.2 J and J Protein and Peptide Therapeutics Product Overview
9.13.3 J and J Protein and Peptide Therapeutics Product Market Performance
9.13.4 J and J Business Overview
9.13.5 J and J Recent Developments
10 PROTEIN AND PEPTIDE THERAPEUTICS MARKET FORECAST BY REGION
10.1 Global Protein and Peptide Therapeutics Market Size Forecast
10.2 Global Protein and Peptide Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Protein and Peptide Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Protein and Peptide Therapeutics Market Size Forecast by Region
10.2.4 South America Protein and Peptide Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Protein and Peptide Therapeutics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Protein and Peptide Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Protein and Peptide Therapeutics by Type (2025-2030)
11.1.2 Global Protein and Peptide Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Protein and Peptide Therapeutics by Type (2025-2030)
11.2 Global Protein and Peptide Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Protein and Peptide Therapeutics Sales (Kilotons) Forecast by Application
11.2.2 Global Protein and Peptide Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Protein and Peptide Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Protein and Peptide Therapeutics Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Protein and Peptide Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Protein and Peptide Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Protein and Peptide Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Protein and Peptide Therapeutics as of 2022)
Table 10. Global Market Protein and Peptide Therapeutics Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Protein and Peptide Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Protein and Peptide Therapeutics Product Type
Table 13. Global Protein and Peptide Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Protein and Peptide Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Protein and Peptide Therapeutics Market Challenges
Table 22. Global Protein and Peptide Therapeutics Sales by Type (Kilotons)
Table 23. Global Protein and Peptide Therapeutics Market Size by Type (M USD)
Table 24. Global Protein and Peptide Therapeutics Sales (Kilotons) by Type (2019-2024)
Table 25. Global Protein and Peptide Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Protein and Peptide Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Protein and Peptide Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Protein and Peptide Therapeutics Price (USD/Ton) by Type (2019-2024)
Table 29. Global Protein and Peptide Therapeutics Sales (Kilotons) by Application
Table 30. Global Protein and Peptide Therapeutics Market Size by Application
Table 31. Global Protein and Peptide Therapeutics Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Protein and Peptide Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Protein and Peptide Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Protein and Peptide Therapeutics Market Share by Application (2019-2024)
Table 35. Global Protein and Peptide Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Protein and Peptide Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Protein and Peptide Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Protein and Peptide Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Protein and Peptide Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Protein and Peptide Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Protein and Peptide Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Protein and Peptide Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 43. Sanofi Protein and Peptide Therapeutics Basic Information
Table 44. Sanofi Protein and Peptide Therapeutics Product Overview
Table 45. Sanofi Protein and Peptide Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Sanofi Business Overview
Table 47. Sanofi Protein and Peptide Therapeutics SWOT Analysis
Table 48. Sanofi Recent Developments
Table 49. Teva Protein and Peptide Therapeutics Basic Information
Table 50. Teva Protein and Peptide Therapeutics Product Overview
Table 51. Teva Protein and Peptide Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Teva Business Overview
Table 53. Teva Protein and Peptide Therapeutics SWOT Analysis
Table 54. Teva Recent Developments
Table 55. Novo Nordisk Protein and Peptide Therapeutics Basic Information
Table 56. Novo Nordisk Protein and Peptide Therapeutics Product Overview
Table 57. Novo Nordisk Protein and Peptide Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Novo Nordisk Protein and Peptide Therapeutics SWOT Analysis
Table 59. Novo Nordisk Business Overview
Table 60. Novo Nordisk Recent Developments
Table 61. Takeda Protein and Peptide Therapeutics Basic Information
Table 62. Takeda Protein and Peptide Therapeutics Product Overview
Table 63. Takeda Protein and Peptide Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Takeda Business Overview
Table 65. Takeda Recent Developments
Table 66. Eli Lilly Protein and Peptide Therapeutics Basic Information
Table 67. Eli Lilly Protein and Peptide Therapeutics Product Overview
Table 68. Eli Lilly Protein and Peptide Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Eli Lilly Business Overview
Table 70. Eli Lilly Recent Developments
Table 71. AstraZeneca Protein and Peptide Therapeutics Basic Information
Table 72. AstraZeneca Protein and Peptide Therapeutics Product Overview
Table 73. AstraZeneca Protein and Peptide Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. AstraZeneca Business Overview
Table 75. AstraZeneca Recent Developments
Table 76. Novartis Protein and Peptide Therapeutics Basic Information
Table 77. Novartis Protein and Peptide Therapeutics Product Overview
Table 78. Novartis Protein and Peptide Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Novartis Business Overview
Table 80. Novartis Recent Developments
Table 81. AbbVie Protein and Peptide Therapeutics Basic Information
Table 82. AbbVie Protein and Peptide Therapeutics Product Overview
Table 83. AbbVie Protein and Peptide Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. AbbVie Business Overview
Table 85. AbbVie Recent Developments
Table 86. Ipsen Protein and Peptide Therapeutics Basic Information
Table 87. Ipsen Protein and Peptide Therapeutics Product Overview
Table 88. Ipsen Protein and Peptide Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Ipsen Business Overview
Table 90. Ipsen Recent Developments
Table 91. Ferring Protein and Peptide Therapeutics Basic Information
Table 92. Ferring Protein and Peptide Therapeutics Product Overview
Table 93. Ferring Protein and Peptide Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Ferring Business Overview
Table 95. Ferring Recent Developments
Table 96. Merck Protein and Peptide Therapeutics Basic Information
Table 97. Merck Protein and Peptide Therapeutics Product Overview
Table 98. Merck Protein and Peptide Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Merck Business Overview
Table 100. Merck Recent Developments
Table 101. The Medicines Protein and Peptide Therapeutics Basic Information
Table 102. The Medicines Protein and Peptide Therapeutics Product Overview
Table 103. The Medicines Protein and Peptide Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. The Medicines Business Overview
Table 105. The Medicines Recent Developments
Table 106. J and J Protein and Peptide Therapeutics Basic Information
Table 107. J and J Protein and Peptide Therapeutics Product Overview
Table 108. J and J Protein and Peptide Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. J and J Business Overview
Table 110. J and J Recent Developments
Table 111. Global Protein and Peptide Therapeutics Sales Forecast by Region (2025-2030) & (Kilotons)
Table 112. Global Protein and Peptide Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Protein and Peptide Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 114. North America Protein and Peptide Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Protein and Peptide Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 116. Europe Protein and Peptide Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Protein and Peptide Therapeutics Sales Forecast by Region (2025-2030) & (Kilotons)
Table 118. Asia Pacific Protein and Peptide Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Protein and Peptide Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 120. South America Protein and Peptide Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Protein and Peptide Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Protein and Peptide Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Protein and Peptide Therapeutics Sales Forecast by Type (2025-2030) & (Kilotons)
Table 124. Global Protein and Peptide Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Protein and Peptide Therapeutics Price Forecast by Type (2025-2030) & (USD/Ton)
Table 126. Global Protein and Peptide Therapeutics Sales (Kilotons) Forecast by Application (2025-2030)
Table 127. Global Protein and Peptide Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Protein and Peptide Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Protein and Peptide Therapeutics Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Protein and Peptide Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Protein and Peptide Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Protein and Peptide Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Protein and Peptide Therapeutics as of 2022)
Table 10. Global Market Protein and Peptide Therapeutics Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Protein and Peptide Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Protein and Peptide Therapeutics Product Type
Table 13. Global Protein and Peptide Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Protein and Peptide Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Protein and Peptide Therapeutics Market Challenges
Table 22. Global Protein and Peptide Therapeutics Sales by Type (Kilotons)
Table 23. Global Protein and Peptide Therapeutics Market Size by Type (M USD)
Table 24. Global Protein and Peptide Therapeutics Sales (Kilotons) by Type (2019-2024)
Table 25. Global Protein and Peptide Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Protein and Peptide Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Protein and Peptide Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Protein and Peptide Therapeutics Price (USD/Ton) by Type (2019-2024)
Table 29. Global Protein and Peptide Therapeutics Sales (Kilotons) by Application
Table 30. Global Protein and Peptide Therapeutics Market Size by Application
Table 31. Global Protein and Peptide Therapeutics Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Protein and Peptide Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Protein and Peptide Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Protein and Peptide Therapeutics Market Share by Application (2019-2024)
Table 35. Global Protein and Peptide Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Protein and Peptide Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Protein and Peptide Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Protein and Peptide Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Protein and Peptide Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Protein and Peptide Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Protein and Peptide Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Protein and Peptide Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 43. Sanofi Protein and Peptide Therapeutics Basic Information
Table 44. Sanofi Protein and Peptide Therapeutics Product Overview
Table 45. Sanofi Protein and Peptide Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Sanofi Business Overview
Table 47. Sanofi Protein and Peptide Therapeutics SWOT Analysis
Table 48. Sanofi Recent Developments
Table 49. Teva Protein and Peptide Therapeutics Basic Information
Table 50. Teva Protein and Peptide Therapeutics Product Overview
Table 51. Teva Protein and Peptide Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Teva Business Overview
Table 53. Teva Protein and Peptide Therapeutics SWOT Analysis
Table 54. Teva Recent Developments
Table 55. Novo Nordisk Protein and Peptide Therapeutics Basic Information
Table 56. Novo Nordisk Protein and Peptide Therapeutics Product Overview
Table 57. Novo Nordisk Protein and Peptide Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Novo Nordisk Protein and Peptide Therapeutics SWOT Analysis
Table 59. Novo Nordisk Business Overview
Table 60. Novo Nordisk Recent Developments
Table 61. Takeda Protein and Peptide Therapeutics Basic Information
Table 62. Takeda Protein and Peptide Therapeutics Product Overview
Table 63. Takeda Protein and Peptide Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Takeda Business Overview
Table 65. Takeda Recent Developments
Table 66. Eli Lilly Protein and Peptide Therapeutics Basic Information
Table 67. Eli Lilly Protein and Peptide Therapeutics Product Overview
Table 68. Eli Lilly Protein and Peptide Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Eli Lilly Business Overview
Table 70. Eli Lilly Recent Developments
Table 71. AstraZeneca Protein and Peptide Therapeutics Basic Information
Table 72. AstraZeneca Protein and Peptide Therapeutics Product Overview
Table 73. AstraZeneca Protein and Peptide Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. AstraZeneca Business Overview
Table 75. AstraZeneca Recent Developments
Table 76. Novartis Protein and Peptide Therapeutics Basic Information
Table 77. Novartis Protein and Peptide Therapeutics Product Overview
Table 78. Novartis Protein and Peptide Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Novartis Business Overview
Table 80. Novartis Recent Developments
Table 81. AbbVie Protein and Peptide Therapeutics Basic Information
Table 82. AbbVie Protein and Peptide Therapeutics Product Overview
Table 83. AbbVie Protein and Peptide Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. AbbVie Business Overview
Table 85. AbbVie Recent Developments
Table 86. Ipsen Protein and Peptide Therapeutics Basic Information
Table 87. Ipsen Protein and Peptide Therapeutics Product Overview
Table 88. Ipsen Protein and Peptide Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Ipsen Business Overview
Table 90. Ipsen Recent Developments
Table 91. Ferring Protein and Peptide Therapeutics Basic Information
Table 92. Ferring Protein and Peptide Therapeutics Product Overview
Table 93. Ferring Protein and Peptide Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Ferring Business Overview
Table 95. Ferring Recent Developments
Table 96. Merck Protein and Peptide Therapeutics Basic Information
Table 97. Merck Protein and Peptide Therapeutics Product Overview
Table 98. Merck Protein and Peptide Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Merck Business Overview
Table 100. Merck Recent Developments
Table 101. The Medicines Protein and Peptide Therapeutics Basic Information
Table 102. The Medicines Protein and Peptide Therapeutics Product Overview
Table 103. The Medicines Protein and Peptide Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. The Medicines Business Overview
Table 105. The Medicines Recent Developments
Table 106. J and J Protein and Peptide Therapeutics Basic Information
Table 107. J and J Protein and Peptide Therapeutics Product Overview
Table 108. J and J Protein and Peptide Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. J and J Business Overview
Table 110. J and J Recent Developments
Table 111. Global Protein and Peptide Therapeutics Sales Forecast by Region (2025-2030) & (Kilotons)
Table 112. Global Protein and Peptide Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Protein and Peptide Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 114. North America Protein and Peptide Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Protein and Peptide Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 116. Europe Protein and Peptide Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Protein and Peptide Therapeutics Sales Forecast by Region (2025-2030) & (Kilotons)
Table 118. Asia Pacific Protein and Peptide Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Protein and Peptide Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 120. South America Protein and Peptide Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Protein and Peptide Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Protein and Peptide Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Protein and Peptide Therapeutics Sales Forecast by Type (2025-2030) & (Kilotons)
Table 124. Global Protein and Peptide Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Protein and Peptide Therapeutics Price Forecast by Type (2025-2030) & (USD/Ton)
Table 126. Global Protein and Peptide Therapeutics Sales (Kilotons) Forecast by Application (2025-2030)
Table 127. Global Protein and Peptide Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Protein and Peptide Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Protein and Peptide Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Protein and Peptide Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Protein and Peptide Therapeutics Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Protein and Peptide Therapeutics Market Size by Country (M USD)
Figure 11. Protein and Peptide Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Protein and Peptide Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Protein and Peptide Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Protein and Peptide Therapeutics Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Protein and Peptide Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Protein and Peptide Therapeutics Market Share by Type
Figure 18. Sales Market Share of Protein and Peptide Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Protein and Peptide Therapeutics by Type in 2023
Figure 20. Market Size Share of Protein and Peptide Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Protein and Peptide Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Protein and Peptide Therapeutics Market Share by Application
Figure 24. Global Protein and Peptide Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Protein and Peptide Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Protein and Peptide Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Protein and Peptide Therapeutics Market Share by Application in 2023
Figure 28. Global Protein and Peptide Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Protein and Peptide Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Protein and Peptide Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Protein and Peptide Therapeutics Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Protein and Peptide Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Protein and Peptide Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Protein and Peptide Therapeutics Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Protein and Peptide Therapeutics Sales Market Share by Region in 2023
Figure 44. China Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Protein and Peptide Therapeutics Sales and Growth Rate (Kilotons)
Figure 50. South America Protein and Peptide Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Protein and Peptide Therapeutics Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Protein and Peptide Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Protein and Peptide Therapeutics Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Protein and Peptide Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Protein and Peptide Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Protein and Peptide Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Protein and Peptide Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Protein and Peptide Therapeutics Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Protein and Peptide Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Protein and Peptide Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Protein and Peptide Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Protein and Peptide Therapeutics Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Protein and Peptide Therapeutics Market Size by Country (M USD)
Figure 11. Protein and Peptide Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Protein and Peptide Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Protein and Peptide Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Protein and Peptide Therapeutics Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Protein and Peptide Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Protein and Peptide Therapeutics Market Share by Type
Figure 18. Sales Market Share of Protein and Peptide Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Protein and Peptide Therapeutics by Type in 2023
Figure 20. Market Size Share of Protein and Peptide Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Protein and Peptide Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Protein and Peptide Therapeutics Market Share by Application
Figure 24. Global Protein and Peptide Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Protein and Peptide Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Protein and Peptide Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Protein and Peptide Therapeutics Market Share by Application in 2023
Figure 28. Global Protein and Peptide Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Protein and Peptide Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Protein and Peptide Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Protein and Peptide Therapeutics Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Protein and Peptide Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Protein and Peptide Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Protein and Peptide Therapeutics Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Protein and Peptide Therapeutics Sales Market Share by Region in 2023
Figure 44. China Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Protein and Peptide Therapeutics Sales and Growth Rate (Kilotons)
Figure 50. South America Protein and Peptide Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Protein and Peptide Therapeutics Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Protein and Peptide Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Protein and Peptide Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Protein and Peptide Therapeutics Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Protein and Peptide Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Protein and Peptide Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Protein and Peptide Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Protein and Peptide Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Protein and Peptide Therapeutics Market Share Forecast by Application (2025-2030)
